<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308343">
  <stage>Registered</stage>
  <submitdate>10/08/2009</submitdate>
  <approvaldate>14/08/2009</approvaldate>
  <actrnumber>ACTRN12609000705280</actrnumber>
  <trial_identification>
    <studytitle>Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease Project</studytitle>
    <scientifictitle>Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives</scientifictitle>
    <utrn />
    <trialacronym>HAPPY trial</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Medication compliance and persistence</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health service research</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A  package of strategies (e.g. Home blood pressure monitoring, motivation interviewing, medication use review, home medicines review (where necessary), patient reminders (SMS, telephone, mail), and general practitioner referral (when needed). This intervention program is for 6 months and will be offered by the pharmacist at baseline, 3 months and 6 months. Each patient is provided with a blood pressure (BP) monitor and advised to carry out home montoring of their blood pressure every 2-3 days.</interventions>
    <comparator>standard care. The patients in the control group will receive the usual care during the 6 months duration. At the end of the study period each control patient will receive a blood pressure monitor.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Persistence and compliance with antihypertensive medicines using Morisky Score and Tool for Adherence Behaviour Screening.</outcome>
      <timepoint>6 months after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in blood pressure control. Each patient is given a blood pressure monitor (Omron HEM-790it) with the capacity to store 200 measurements and is advised to carry out home montioring every 2-3 days. At 3 and 6 months the pharmacist will download patients' home BP recordings, review and discuss compliance issues.</outcome>
      <timepoint>6 months after randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Using or have used one or more antihypertensive medications (angiotensin converting enzyme inhibitors, angiotensin-II receptor antagonists, calcium channel blockers, beta blockers and thiazide diuretics) in the last 6 months, primary hypertension confirmed by the GP, and
available for follow-up at 6 months.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Participation in other compliance promotion or medication profiling programs or receipt of a recent home medicines review, unavailable for follow-up, unable to 
communicate in English, and does not self-
administer anti-hypertensive medicines.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation was done at the pharmacy level through a central randomisation using  sealed opaque envelopes.</concealment>
    <sequence>Stratified allocation through Pharmacy Access/ Remoteness Index of Australia (PhARIA).</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Other</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>17/06/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>450</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Monash</primarysponsorname>
    <primarysponsoraddress>Department of Pharmacy Practice, 
Faculty of Pharmacy and Pharmaceutical Sciences,
Monash University (Parkville Campus),
381 Royal Parade,
Parkville, 
Victoria 3052.</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Australian Government Department of Health and Ageing as part of the Fourth Community Pharmacy Agreement through the Fourth Community Pharmacy Agreement Grants Program managed by the Pharmacy Guild of Australia</fundingname>
      <fundingaddress>GPO Box 9848, 
Canberra, 
ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Curtin University of Technology</sponsorname>
      <sponsoraddress>Bentley Campus,
Kent Street,
Bentley,
Western Australia 6102.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>University of Tasmania</othercollaboratorname>
      <othercollaboratoraddress>Sandy Bay Campus,
Churchill Avenue,
Sandy Bay,
Tasmania 7005.</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash University Human Research Ethics Committee</ethicname>
      <ethicaddress>Monash Research Office
Building 3e
Monash University
Clayton campus
Victoria 3800</ethicaddress>
      <ethicapprovaldate>22/12/2008</ethicapprovaldate>
      <hrec>CF08/3281 - 2008001602</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Prof Kay Stewart</name>
      <address>Department of Pharmacy Practice
Faculty of Pharmacy and Pharmaceutical Sciences
Monash University
Parkville Campus
381 Royal Parade
Parkville 
Victoria 3052</address>
      <phone>+61 (03) 9903 9618</phone>
      <fax>+61 (03) 9903 9629</fax>
      <email>Kay.Stewart@pharm.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>A/Prof Kay Stewart</name>
      <address>Department of Pharmacy Practice
Faculty of Pharmacy and Pharmaceutical Sciences
Monash University
Parkville Campus
381 Royal Parade
Parkville 
Victoria 3052</address>
      <phone>+61 (03) 9903 9618</phone>
      <fax>+61 (03) 9903 9629</fax>
      <email>Kay.Stewart@pharm.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Rosalind Lau</name>
      <address>Department of Pharmacy Practice
Faculty of Pharmacy and Pharmaceutical Sciences
Monash University
Parkville Campus
381 Royal Parade
Parkville 
Victoria 3052</address>
      <phone>+61 (03) 9903 9001</phone>
      <fax>+61 (03) 9903 9629</fax>
      <email>Rosalind.Lau@pharm.monash.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>